| 1 |
Borges GSM, Sicard P, de Mello Gomides Loures C, Evangelista FGC, Sales CC, de Paula Sabino A, Fernandes C, Ferreira LAM, Richard S. Tocotrienols-enriched Self-nanoemulsifying Drug Delivery System Enhances the Antileukemic Activity of All-trans Retinoic Acid but not Electrocardiogram Alterations Evoked by Its Combination with Arsenic Trioxide. AAPS PharmSciTech 2023;24:79. [PMID: 36918482 DOI: 10.1208/s12249-023-02531-w] [Reference Citation Analysis]
|
| 2 |
Liu J, Li X, Chen J, Zhang X, Guo J, Gu J, Mei C, Xiao Y, Peng C, Liu J, Hu X, Zhang K, Li D, Zhou B. Arsenic-Loaded Biomimetic Iron Oxide Nanoparticles for Enhanced Ferroptosis-Inducing Therapy of Hepatocellular Carcinoma. ACS Appl Mater Interfaces 2023;15:6260-73. [PMID: 36695492 DOI: 10.1021/acsami.2c14962] [Reference Citation Analysis]
|
| 3 |
Hollow SE, Johnstone TC. Realgar and arsenene nanomaterials as arsenic-based anticancer agents. Curr Opin Chem Biol 2023;72:102229. [PMID: 36413888 DOI: 10.1016/j.cbpa.2022.102229] [Reference Citation Analysis]
|
| 4 |
Zhou W, Wang F, Li A, Bai S, Feng X, He Q. A Superphane-based carcerand for arsenic detoxification via imprisoning arsenate. Cell Reports Physical Science 2023. [DOI: 10.1016/j.xcrp.2023.101295] [Reference Citation Analysis]
|
| 5 |
Skoczynska A, Skoczynska M. Breast Cancer and Arsenic Anticancer Effects: Systematic Review of the Experimental Data from In Vitro Studies. Biomed Res Int 2022;2022:8030931. [PMID: 36619302 DOI: 10.1155/2022/8030931] [Reference Citation Analysis]
|
| 6 |
Yang F, Wynn DT, Shen C, Ayad NG, Robbins DJ. Multiprotein GLI Transcriptional Complexes as Therapeutic Targets in Cancer. Life (Basel) 2022;12. [PMID: 36556332 DOI: 10.3390/life12121967] [Reference Citation Analysis]
|
| 7 |
Mukherjee AG, Wanjari UR, Gopalakrishnan AV, Bradu P, Sukumar A, Patil M, Renu K, Dey A, Vellingiri B, George A, Ganesan R. Implications of cancer stem cells in diabetes and pancreatic cancer. Life Sci 2022;312:121211. [PMID: 36414089 DOI: 10.1016/j.lfs.2022.121211] [Reference Citation Analysis]
|
| 8 |
Sun J, Cheng M, Ye T, Li B, Wei Y, Zheng H, Zheng H, Zhou M, Piao JG, Li F. Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy. Nanomedicine (Lond) 2022;17:2037-54. [PMID: 36789952 DOI: 10.2217/nnm-2022-0250] [Reference Citation Analysis]
|
| 9 |
Chin L, Kumana CR, Kwong Y, Gill H. The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases. Pharmaceutics 2022;14:1945. [DOI: 10.3390/pharmaceutics14091945] [Reference Citation Analysis]
|
| 10 |
Genchi G, Lauria G, Catalano A, Carocci A, Sinicropi MS. Arsenic: A Review on a Great Health Issue Worldwide. Applied Sciences 2022;12:6184. [DOI: 10.3390/app12126184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
